Xolair 75 MG/0.5 ML autoinject 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FX2FR
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,703
Award facts
- Contract value 100% obligated
- $1,702.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of XOLAIR 75 mg/0.5 mL auto-injector units. This firm fixed-price delivery order, valued at $1,702.68, was issued on September 26, 2025, with an ultimate completion date of October 20, 2025. The contract carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on its merits as a qualified federal supplier. XOLAIR is a biologic medication used to treat moderate-to-severe allergic asthma and chronic idiopathic urticaria, representing a specialized pharmaceutical product critical to military and federal healthcare operations.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency's SPE2DB program, a $499.999 billion contract vehicle through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies for Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group's established position as a primary distributor in the federal pharmaceutical supply chain reflects the company's capability to reliably deliver both branded and generic prescription medications, biologics, and medical consumables essential to military health operations globally.
Quick answers
Who was awarded contract SPE2DB25FX2FR?
SPE2DB25FX2FR was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FX2FR worth?
The government has obligated $1,703 on SPE2DB25FX2FR.
Is contract SPE2DB25FX2FR an order under another contract?
Yes. SPE2DB25FX2FR is a delivery order under SPE2DB22D9353, an indefinite delivery contract.
Was contract SPE2DB25FX2FR competed?
The extent of competition for SPE2DB25FX2FR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award